🇺🇸 RAMOSETRON HYDROCHLORIDE in United States

322 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Platelet Count Decreased — 40 reports (12.42%)
  2. White Blood Cell Count Decreased — 37 reports (11.49%)
  3. Pyrexia — 35 reports (10.87%)
  4. Anaemia — 32 reports (9.94%)
  5. Diarrhoea — 32 reports (9.94%)
  6. Nausea — 32 reports (9.94%)
  7. Pneumonia — 31 reports (9.63%)
  8. Febrile Neutropenia — 30 reports (9.32%)
  9. Neutrophil Count Decreased — 30 reports (9.32%)
  10. Sepsis — 23 reports (7.14%)

Source database →

RAMOSETRON HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is RAMOSETRON HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for RAMOSETRON HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.